Translocator Protein Distribution Volume Predicts Reduction of Symptoms During Open-Label Trial of Celecoxib in Major Depressive Disorder
Sophia Attwells, Elaine Setiawan, Pablo Rusjan, Cynthia Xu, Celeste Hutton, Dorsa Rafiei, Benjamin Varughese, Alan Kahn, Stephen J. Kish, Neil Vasdev, Sylvain Houle, Jeffrey H. Meyer
Topics & Concepts
Translocator proteinGliosisCelecoxibInternal medicineMedicineMajor depressive disorderPositron emission tomographyAnterior cingulate cortexPathologyPsychiatryNuclear medicineDiseaseCognitionNeuroinflammationAmygdalaTryptophan and brain disordersTreatment of Major DepressionNeuroscience and Neuropharmacology Research